Expression of Fas receptor on peripheral blood lymphocytes from patients with non-small cell lung cancer.
In recent years many data indicate that lymphocytes from cancer patients undergo increased apoptosis. The objective of this study was to evaluate the expression of Fas receptor on lymphocytes obtained from patients with lung cancer. Eighteen patients with non-small cell lung cancer and 18 healthy volunteers were investigated. Expression of Fas (CD95) on CD4+ and CD8+ blood lymphocytes was evaluated by flow cytometry. The proportion of blood Fas+ lymphocytes was significantly higher in lung cancer patients when compared with healthy individuals and in smokers when compared with nonsmokers.
Hoser
Grazyna
G
Department of Clinical Cytology, Medical Center of Postgraduate Education, Medical University, Warsaw, Poland. graho@cmkp.edu.pl
Wasilewska
Danuta
D
Domagała-Kulawik
Joanna
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism*; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood*; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D008214:Lymphocytes / Q000097:blood*; D008297:Male; D008875:Middle Aged; D019014:fas Receptor / Q000032:analysis / Q000096:biosynthesis*
D019014:fas Receptor